Webinar: Is It Safe? Safety Surveillance through the Antiretroviral Pregnancy Registry - March 2, 2017

Thursday, March 2, 2017
1:00 pm – 2:00 pm ET | 12:00 pm – 1:00 pm CT | 11:00 am – 12:00 pm MT | 10:00 am – 11:00am PT
Provided by CDC's Elimination of Perinatal HIV Transmission Stakeholders Group

PRESENTER:

  • William Short, MD, MPH, AAHIVS, University of Pennsylvania, Philadelphia, Pennsylvania

WITH DISCUSSION AND COMMENTARY BY:

  • Lynne Mofenson, MD, Elizabeth Glaser Pediatric AIDS Foundation and
  • Hugh Tilson, MD, DrPH, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina

OBJECTIVES:

At the end of this webinar, participants will:

  • Describe three objectives of the Antiretroviral Pregnancy Registry (APR).
  • List two key findings from analysis of APR data.
  • Describe four steps to report a drug exposure to the APR.

**Continuing education credit for this webinar is available. For more information, see flyer.**

TO REGISTER: https://aetc.adobeconnect.com/e9cgigsrj3l/event/registration.html

like0

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in your inbox.

seventh name

Treatment 103: The Basics of Clinical Trials and Bio-Medical Research was the sixth in our eight-week webinar series that offers women living with HIV capacity building and training on HIV disease and treatment advocacy.

Get some great tips about traveling with HIV. Learn about packing your pills, adjusting your dosing schedule, and traveling abroad.

Obtener información acerca de la profilaxis pre-exposición (PrEP), cómo funciona, lo que dice la investigación, las nuevas directrices para el uso de Truvada como PrEP, y mucho más.

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>